Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Finished Goods (2020 - 2025)

Fortress Biotech (FBIO) has 6 years of Finished Goods data on record, last reported at $10.0 million in Q1 2025.

  • For Q1 2025, Finished Goods rose 70.95% year-over-year to $10.0 million; the TTM value through Mar 2025 reached $10.0 million, up 70.95%, while the annual FY2024 figure was $11.4 million, 128.21% up from the prior year.
  • Finished Goods reached $10.0 million in Q1 2025 per FBIO's latest filing, down from $11.4 million in the prior quarter.
  • Across five years, Finished Goods topped out at $11.4 million in Q4 2024 and bottomed at $4.3 million in Q4 2021.
  • Average Finished Goods over 5 years is $7.3 million, with a median of $7.1 million recorded in 2023.
  • Peak YoY movement for Finished Goods: soared 205.56% in 2021, then plummeted 35.56% in 2023.
  • A 5-year view of Finished Goods shows it stood at $4.3 million in 2021, then skyrocketed by 80.4% to $7.7 million in 2022, then crashed by 35.56% to $5.0 million in 2023, then skyrocketed by 128.21% to $11.4 million in 2024, then dropped by 11.91% to $10.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Finished Goods were $10.0 million in Q1 2025, $11.4 million in Q4 2024, and $8.7 million in Q3 2024.